1. Home
  2. CTNM vs AEXA Comparison

CTNM vs AEXA Comparison

Compare CTNM & AEXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Contineum Therapeutics Inc.

CTNM

Contineum Therapeutics Inc.

N/A

Current Price

$17.05

Market Cap

550.7M

Sector

N/A

ML Signal

N/A

AEXA

American Exceptionalism Acquisition Corp. A

N/A

Current Price

$11.50

Market Cap

557.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CTNM
AEXA
Founded
2009
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
550.7M
557.4M
IPO Year
2024
2025

Fundamental Metrics

Financial Performance
Metric
CTNM
AEXA
Price
$17.05
$11.50
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
541.9K
45.3K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
0.46
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.60
$10.49
52 Week High
$17.51
$11.99

Technical Indicators

Market Signals
Indicator
CTNM
AEXA
Relative Strength Index (RSI) 63.03 47.44
Support Level $13.65 $11.02
Resistance Level N/A $11.81
Average True Range (ATR) 0.98 0.22
MACD 0.18 -0.01
Stochastic Oscillator 88.27 41.23

Price Performance

Historical Comparison
CTNM
AEXA

About CTNM Contineum Therapeutics Inc.

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.

About AEXA American Exceptionalism Acquisition Corp. A

American Exceptionalism Acquisition Corp A is a blank check company.

Share on Social Networks: